Article
Detection of Brain Tumor Cells in the Peripheral Blood by a Telomerase Promoter-Based Assay
13 Feb 2014
Abstract excerpt
Blood tests to detect circulating tumor cells (CTC) offer great potential to monitor disease status, gauge prognosis, and guide treatment decisions for patients with cancer. For patients with brain tumors, such as aggressive glioblastoma multiforme, CTC assays are needed that do not rely on expression of cancer cell surface biomarkers like epithelial cell adhesion molecules that brain tumors tend to lack. Here,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
